Spironolactone Tablet, Film Coated
Product Images NDC 63629-2437

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-2437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Structure)

Image Description (Structure)
Chemical structure diagram of spironolactone, the active ingredient in Spironolactone 25 mg film-coated tablets. The image shows the molecular arrangement with labeled chemical groups and bonds.*
FDA Label Image

Image Description (Figure 1)

Image Description (Figure 1)
A Kaplan-Meier plot comparing survival probabilities over 48 months between Spironolactone and placebo groups. The y-axis represents probability, and the x-axis represents months. The Spironolactone group shows higher survival probabilities compared to placebo, with a statistically significant difference (Log-rank p < 0.001).*
FDA Label Image

Image Description (Figure 2)

Image Description (Figure 2)
A forest plot showing hazard ratios (HR) with 95% confidence intervals (CI) for spironolactone versus placebo across various subgroups, including age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, and use of digoxin, ACE inhibitors, and beta blockers. The plot visualizes the comparative effects of spironolactone in these subgroups.*
FDA Label Image

Label (Lbl636292437)

Label (Lbl636292437)
Label for Spironolactone Tablets, USP 25 mg, film-coated oral tablets by Bryant Ranch Prepack. The label shows NDC 63629-2437-1, a barcode, and specifies a package size of 500 tablets. It includes storage instructions and child-resistant container guidance. The BRP Pharmaceuticals logo is visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.